The charity pledge
iGovy exists to make UK medicine prices honest and comparable. The pledge sends a fixed share of what the site earns to health causes.
Last checked 3 Nov 2026
20 percent of profits from the Medstack network, including iGovy, is pledged to health charities.
Why the pledge exists
Price comparison in healthcare carries a responsibility that comparing broadband deals does not. People arrive here making decisions about their health under cost pressure, and the site earns from some of the links they follow. The pledge keeps that relationship honest. A fixed share of what the network earns is committed to health charities, so the incentive to grow the site is also an incentive to grow what goes to good causes.
How it works alongside independence
- Ranking is never for sale: price tables order by checked price. Links that support the site never change a position, and the pledge does not change that either.
- No cost to you: supported links never affect the price you pay. The pledge comes from the network's share, not yours.
- Network wide: the pledge covers the Medstack network of comparison sites, of which iGovy is one, alongside Monj and Ogovy.
Independence note: iGovy does not sell, prescribe or dispense medicines. The full verification and pricing method is on how iGovy checks prices and GPhC verification.
Page accountability: Nick Johnson, Independent Prescription Pricing Analyst at Medstack Ltd, is responsible for this pledge and this page. Questions about it are welcome via the site contact route.
Sources referenced on this page
Standing primary references for every iGovy page:
- Wegovy (semaglutide) Summary of Product Characteristics and Patient Information Leaflet, electronic medicines compendium
- MHRA Drug Safety Update: GLP-1 receptor agonists
- NICE TA875: semaglutide for managing overweight and obesity
- General Pharmaceutical Council register of pharmacies
- MHRA Yellow Card scheme
